Diorin 450 mg+50 mg (Tablet)
Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Diosmin hesperidin |
| Company | Incepta pharmaceuticals ltd |
Indications
- Acute hemorrhoidal attacks
- Chronic hemorrhoidal disease
- Organic and functional chronic venous insufficiency of the lower limbs with symptoms: heavy legs, pain, nocturnal cramps
Composition
- Diosmin micronised BP 450 mg
- Hesperidin micronised INN 50 mg
- Diosmin micronised BP 900 mg
- Hesperidin micronised USP 100 mg
Pharmacology
- Phlebotonic drug
- Vascular protecting agent
- Reinforces venous tone
- Decreases venous capacitance
- Decreases venous distensibility
- Decreases venous emptying time
- Protects microcirculation
- Fights microcirculation damaging process
- Combats venous inflammation
- Normalizes capillary permeability
- Strengthens capillary resistance
- Acts on the lymphatic system
- Improves lymphatic drainage
- Increases lymph flow
- Increases lymph oncotic pressure
Dosage
- Recommended dosage for acute hemorrhoidal attacks
- Recommended dosage for chronic hemorrhoids
- Recommended dosage for chronic venous insufficiency
- Different dosages for Diosmin 450 mg & Hesperidin 50 mg
- Different dosages for Diosmin 900 mg & Hesperidin 100 mg
Administration
- Tablet should be taken at meal times
Interaction
- No evidence of drug incompatibility reported in clinical trials
Contraindications
- Chronic venous insufficiency and complications should be diagnosed and managed by a physician
- Contraindicated for individuals with hypersensitivity to any ingredient
Side Effects
- Reported cases of routine gastric disorders
- Reported cases of neurovegetative disorders
- Discontinuation of treatment not required
Pregnancy & Lactation
- Experimental studies in animals showed no teratogenic effect
- No harmful effects reported in human beings
- Breastfeeding not recommended during treatment due to lack of data concerning excretion into breast milk
Precautions & Warnings
- If hemorrhoidal symptoms persist beyond 15 days, consult a doctor
- Diosmin (up to 900 mg/day) administered to breast cancer patients with lymphedema
- No evidence of carcinogenicity or mutagenicity in animal studies and clinical use in Europe
- Not recommended for patients with a history of cancer
Therapeutic Class
- Phlebotonic & Vascular protecting preparation
Storage Conditions
- Keep below 30°C temperature
- Keep away from light & moisture
- Keep out of the reach of children